title: Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.
abstract: Angiogenesis plays a critical role in tumor growth. VEGF, angiopoietins (Ang-1, Ang-2) and their tyrosine kinase receptor Tie2 are major regulators of angiogenesis. The aim of this study was to evaluate the prognostic value of the serum levels of these factors in bladder cancer. We analyzed the serum samples of 117 bladder cancer patients and 64 healthy volunteers by enzyme linked immunosorbent assay (ELISA) for Ang-1, Ang-2, VEGF and the extracellular domain of Tie2. The statistical evaluation of the obtained data was performed via Kaplan-Meier log-rank test, univariate Cox analyses as well as Cox proportional hazards regression model. Serum Ang-1 levels of bladder cancer patients were significantly higher (p < 0.001), while soluble Ang-2 and Tie2 levels were significantly lower (p = 0.016 and p = 0.001 respectively) in patients than those in controls. Cox univariate analysis revealed high sTie2 serum level as a risk factor for metastasis and as a borderline significant risk factor for disease related death (p = 0.022 and p = 0.081 respectively). These correlations were independent from tumor stage and grade in a Cox multivariate model (p = 0.016 and p = 0.069). These data indicate that the serum levels of analyzed angiogenic factors do change characteristically in bladder cancer. The soluble extracellular serum level of Tie2 may provide a stage and grade independent diagnostic tool to select a high risk group of bladder cancer patients.
authors.affiliation: Experimental Urology, Department of Urology, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany. sztibusz@gmail.com
authors.forename: Tibor
authors.initials: T
authors.lastname: Szarvas
authors.forename: Tobias
authors.initials: T
authors.lastname: Jäger
authors.forename: Falk
authors.initials: F
authors.lastname: Droste
authors.forename: Markus
authors.initials: M
authors.lastname: Becker
authors.forename: Ilona
authors.initials: I
authors.lastname: Kovalszky
authors.forename: Imre
authors.initials: I
authors.lastname: Romics
authors.forename: Süleyman
authors.initials: S
authors.lastname: Ergün
authors.forename: Herbert
authors.initials: H
authors.lastname: Rübben
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D042682:Angiopoietins / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019042:Muscle Neoplasms / Q000097:blood* / Q000556:secondary; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D042787:Receptor, TIE-2 / Q000097:blood*; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
chemical_list: D042682:Angiopoietins; D014408:Biomarkers, Tumor; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D042787:Receptor, TIE-2